Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Hyperestrogenism

Introduction

Overview

Overview

Hyperestrogenism, or estrogen excess, is a medical condition characterized by an excessive amount of estrogenic activity in the body.[1]

Causes

Causes

Hyperestrogenism can be caused by ovarian tumors,[2] genetic conditions such as aromatase excess syndrome (also known as familial hyperestrogenism), or overconsumption of exogenous sources of estrogen, including medications used in hormone replacement therapy and hormonal contraception.[3]

Signs and symptoms

Signs and symptoms

Signs of hyperestrogenism may include heightened levels of one or more of the estrogen sex hormones (usually estradiol and/or estrone), lowered levels of follicle-stimulating hormone and/or luteinizing hormone (due to suppression of the hypothalamic-pituitary-gonadal axis by estrogen), and lowered levels of androgens such as testosterone (generally only relevant to males).[1] Symptoms of the condition in women may consist of menstrual irregularities, amenorrhea, abnormal vaginal bleeding, and enlargement of the uterus and breasts.[2][1] It may also present as isosexual precocity in children[2][1] and as hypogonadism, gynecomastia, feminization, impotence, and loss of libido in males.[3] If left untreated, hyperestrogenism may increase the risk of estrogen-sensitive cancers such as breast cancer later in life.

Treatments

Treatments

Treatment may consist of surgery in the case of tumors,[1] lower doses of estrogen in the case of exogenously-mediated estrogen excess, and estrogen-suppressing medications like gonadotropin-releasing hormone analogues and progestogens. In addition, androgens may be supplemented in the case of males.

See also

See also

References

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 Norman Lavin (1 April 2009). Manual of Endocrinology and Metabolism. Lippincott Williams & Wilkins. p. 274. ISBN 978-0-7817-6886-3. Retrieved 5 June 2012.
  2. ↑ 2.0 2.1 2.2 Ricardo V. Lloyd (14 January 2010). Endocrine Pathology:: Differential Diagnosis and Molecular Advances. Springer. p. 316. ISBN 978-1-4419-1068-4. Retrieved 5 June 2012.
  3. ↑ 3.0 3.1 Lewis R. Goldfrank; Neal Flomenbaum (24 March 2006). Goldfrank’s Toxicologic Emergencies. McGraw-Hill Professional. p. 443. ISBN 978-0-07-147914-1. Retrieved 5 June 2012.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]